1
TITLE: Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era  Full Text
AUTHORS: Schreiber, Stefan; Ben Horin, Shomron; Alten, Rieke; Westhovens, Rene; Peyrin Biroulet, Laurent; Danese, Silvio; Hibi, Toshifumi; Takeuchi, Ken; Magro, Fernando; An, Yoorim; Kim, Dong Hyeon; Yoon, SangWook; Reinisch, Walter;
PUBLISHED: 2022, SOURCE: ADVANCES IN THERAPY, VOLUME: 39, ISSUE: 6
INDEXED IN: Scopus WOS
2
TITLE: Detection of anti-infliximab antibodies is impacted by antibody titer, infliximab level and IgG4 antibodies: a systematic comparison of three different assays
AUTHORS: Joana Afonso ; Susana Lopes; Raquel Gonçalves; Paulo Caldeira; Paula Lago; Helena Tavares de Sousa; Jaime Ramos; Ana Rita Gonçalves; Paula Ministro; Isadora Rosa; Ana Isabel Vieira; Rosa Coelho; Patrícia Tavares; João Soares; Ana Lúcia Sousa; Diana Carvalho; Paula Sousa; João Pereira da Silva; Tânia Meira; Filipa Silva Ferreira; Cláudia Camila Dias ; Yehuda Chowers; Shomron Ben-Horin; Fernando Magro ; on behalf Portuguese IBD Study Group (GEDII), ; ...More
PUBLISHED: 2016, SOURCE: THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, VOLUME: 9, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 15